Video Latest - ecancer

Developments with PD1 and immunotherapy in melanoma

Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France

19 Jul 2013

Establishing immunotherapy as a standard in cancer treatment

Prof Drew Pardoll – Johns Hopkins University School of Medicine, Baltimore, USA

18 Jul 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks

11 Jul 2013

Relapsed or progressive multiple myeloma

Dr Ruben Niesvizky - Weill Cornell Medical College, New York, USA

20 Jun 2013

Vemurafenib and ipilimumab for metastatic melanoma

Dr Caroline Robert - Institute Gustave Roussy, Paris, France

14 Jun 2013

Importance of the immune system in cancer

Prof Leif Håkansson - Linköping University Hospital, Sweden

14 Jun 2013

Monoclonal antibodies and targeting them against cancer cells in lymphoma

Prof Ronald Levy - Stanford University, USA

14 Jun 2013

Role of microenvironment and stroma in cancer therapy

Dr Stephen Ansell - Mayo Clinic, Rochester, USA

7 Jun 2013

ASCO 2013 highlights

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab

Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA

3 Jun 2013

Nivolumab blocking PD1 in lung cancer and melanoma

Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA

3 Jun 2013

Development and clinical trials of Z100

Dr Keiichi Fujiwara - Saitama Medical University, Saitama, Japan

3 Jun 2013

Video